Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,736 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessment of plaque evolution in coronary bifurcations located beyond everolimus eluting scaffolds: serial intravascular ultrasound virtual histology study.
Lee IS, Bourantas CV, Muramatsu T, Gogas BD, Heo JH, Diletti R, Farooq V, Zhang Y, Onuma Y, Serruys PW, Garcia-Garcia HM. Lee IS, et al. Among authors: muramatsu t. Cardiovasc Ultrasound. 2013 Jul 20;11:25. doi: 10.1186/1476-7120-11-25. Cardiovasc Ultrasound. 2013. PMID: 23870248 Free PMC article. Clinical Trial.
Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
Gogas BD, Garcia-Garcia HM, Onuma Y, Muramatsu T, Farooq V, Bourantas CV, Serruys PW. Gogas BD, et al. Among authors: muramatsu t. JACC Cardiovasc Interv. 2013 Mar;6(3):211-21. doi: 10.1016/j.jcin.2013.01.132. JACC Cardiovasc Interv. 2013. PMID: 23517830 Free article. Review.
Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials.
Muramatsu T, Onuma Y, García-García HM, Farooq V, Bourantas CV, Morel MA, Li X, Veldhof S, Bartorelli A, Whitbourn R, Abizaid A, Serruys PW; ABSORB-EXTEND Investigators. Muramatsu T, et al. JACC Cardiovasc Interv. 2013 Mar;6(3):247-57. doi: 10.1016/j.jcin.2012.10.013. JACC Cardiovasc Interv. 2013. PMID: 23517836 Free article. Clinical Trial.
The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials.
Gogas BD, Bourantas CV, Garcia-Garcia HM, Onuma Y, Muramatsu T, Farooq V, Diletti R, van Geuns RJ, De Bruyne B, Chevalier B, Thuesen L, Smits PC, Dudek D, Koolen J, Windecker S, Whitbourn R, McClean D, Dorange C, Miquel-Hebert K, Veldhof S, Rapoza R, Ormiston JA, Serruys PW. Gogas BD, et al. Among authors: muramatsu t. EuroIntervention. 2013 Oct;9(6):709-20. doi: 10.4244/EIJV9I6A115. EuroIntervention. 2013. PMID: 23628499 Free article.
Coronary evaginations are associated with positive vessel remodelling and are nearly absent following implantation of newer-generation drug-eluting stents: an optical coherence tomography and intravascular ultrasound study.
Radu MD, Räber L, Kalesan B, Muramatsu T, Kelbæk H, Heo J, Jørgensen E, Helqvist S, Farooq V, Brugaletta S, Garcia-Garcia HM, Jüni P, Saunamäki K, Windecker S, Serruys PW. Radu MD, et al. Among authors: muramatsu t. Eur Heart J. 2014 Mar;35(12):795-807. doi: 10.1093/eurheartj/eht344. Epub 2013 Oct 16. Eur Heart J. 2014. PMID: 24132187 Free article.
Clinical and angiographic characteristics of patients likely to have vulnerable plaques: analysis from the PROSPECT study.
Bourantas CV, Garcia-Garcia HM, Farooq V, Maehara A, Xu K, Généreux P, Diletti R, Muramatsu T, Fahy M, Weisz G, Stone GW, Serruys PW. Bourantas CV, et al. Among authors: muramatsu t. JACC Cardiovasc Imaging. 2013 Dec;6(12):1263-72. doi: 10.1016/j.jcmg.2013.04.015. Epub 2013 Oct 23. JACC Cardiovasc Imaging. 2013. PMID: 24269259 Free article.
Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months.
Serruys PW, Onuma Y, Garcia-Garcia HM, Muramatsu T, van Geuns RJ, de Bruyne B, Dudek D, Thuesen L, Smits PC, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Hebert KM, Rapoza R, Ormiston JA. Serruys PW, et al. Among authors: muramatsu t. EuroIntervention. 2014 Mar 20;9(11):1271-84. doi: 10.4244/EIJV9I11A217. EuroIntervention. 2014. PMID: 24291783 Free article. Clinical Trial.
Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
Girasis C, Farooq V, Diletti R, Muramatsu T, Bourantas CV, Onuma Y, Holmes DR, Feldman TE, Morel MA, van Es GA, Dawkins KD, Morice MC, Serruys PW. Girasis C, et al. Among authors: muramatsu t. JACC Cardiovasc Interv. 2013 Dec;6(12):1250-60. doi: 10.1016/j.jcin.2013.08.009. JACC Cardiovasc Interv. 2013. PMID: 24355115 Free article. Clinical Trial.
1,736 results